![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 16
2021
Shi, Run; Bao, Xuanwen; Unger, Kristian; Sun, Jing; Lu, Shun; Manapov, Farkhad; Wang, Xuanbin; Belka, Claus und Li, Minglun
(2021):
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
In: Theranostics, Bd. 11, Nr. 10: S. 5061-5076
2020
Shi, Run; Bao, Xuanwen; Sun, Jing; Lu, Shun; Belka, Claus 
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, Minglun
(2020):
Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes.
In: Clinical and Translational Medicine, Bd. 10, Nr. 5, e187
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, Minglun
(2020):
Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes.
In: Clinical and Translational Medicine, Bd. 10, Nr. 5, e187
[PDF, 2MB]
Bao, Xuanwen; Wang, Jing; Zhou, Guangming; Aszodi, Attila; Schoenitzer, Veronika; Scherthan, Harry; Atkinson, Michael J. und Rosemann, Michael
(2020):
Extended in vitro culture of primary human mesenchymal stem cells downregulates Brca1-related genes and impairs DNA double-strand break recognition.
In: FEBS Open Bio, Bd. 10, Nr. 7: S. 1238-1250
Sun, Jing; Zhao, Tianyu; Zhao, Di; Qi, Xin; Bao, Xuanwen; Shi, Run und Su, Chuan
(2020):
Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients.
In: Therapeutic Advances in Medical Oncology, Bd. 12
Shi, Run; Bao, Xuanwen; Weischenfeldt, Joachim; Schaefer, Christian; Rogowski, Paul; Schmidt-Hegemann, Nina-Sophie; Unger, Kristian; Lauber, Kirsten; Wang, Xuanbin; Buchner, Alexander; Stief, Christian; Schlomm, Thorsten; Belka, Claus und Li, Minglun
(2020):
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.
In: Cancers, Bd. 12, Nr. 1, 1
Shi, Run; Bao, Xuanwen; Rogowski, Paul; Schaefer, Christian; Schmidt-Hegemann, Nina-Sophie; Unger, Kristian; Lu, Shun; Sun, Jing; Buchner, Alexander; Stief, Christian; Belka, Claus und Li, Minglun
(2020):
Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer.
In: Cancers, Bd. 12, Nr. 5, 1146
Bao, Xuanwen; Shi, Run; Zhao, Tianyu und Wang, Yanfang
(2020):
Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma.
In: Molecular Oncology, Bd. 14, Nr. 5: S. 917-932
Bao, Xuanwen; Shi, Run; Zhao, Tianyu und Wang, Yanfang
(2020):
Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.
In: Journal of Molecular Medicine-Jmm, Bd. 98, Nr. 6: S. 805-818
Bao, Xuanwen; Shi, Run; Zhao, Tianyu; Wang, Yanfang; Anastasov, Natasa; Rosemann, Michael und Fang, Weijia
(2020):
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
In: Cancer Immunology Immunotherapy, Bd. 70, Nr. 1: S. 189-202
2019
Bao, Xuanwen; Shi, Run; Zhang, Kai; Xin, Shan; Li, Xin; Zhao, Yanbo und Wang, Yanfang
(18. September 2019):
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature.
In: Frontiers in Oncology, Bd. 9, 903: S. 1-15
[PDF, 2MB]
Wang, Yanfang; Deng, Haowen; Xin, Shan; Zhang, Kai; Shi, Run und Bao, Xuanwen
(24. April 2019):
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
In: Frontiers in Genetics, Bd. 10, 349
[PDF, 11MB]
Bao, Xuanwen; Anastasov, Natasa; Wang, Yanfang und Rosemann, Michael
(2019):
A novel epigenetic signature for overall survival prediction in patients with breast cancer.
In: Journal of Translational Medicine, Bd. 17, Nr. 1, 380
Bao, Maode; Shi, Run; Zhang, Kai; Zhao, Yanbo; Wang, Yanfang und Bao, Xuanwen
(2019):
Development of a membrane lipid metabolism-based signature to predict overall survival for personalized medicine in ccRCC patients.
In: Epma Journal, Bd. 10, Nr. 4: S. 383-393
Wang, Yanfang; Xin, Shan; Zhang, Kai; Shi, Run und Bao, Xuanwen
(2019):
Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas.
In: Journal of Oncology, Bd. 2019, 1785042
[PDF, 9MB]
Wang, Yanfang; Zhang, Quanli; Gao, Zhaojia; Xin, Shan; Zhao, Yando; Zhang, Kai; Shi, Run und Bao, Xuanwen
(2019):
A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis.
In: Cancer Cell International, Bd. 19, 100
2018
Wang, Ji; Wang, Jing; Zhang, Kai; Wang, Yanfang und Bao, Xuanwen
(2018):
Bayesian Network Meta-Analysis of the Effectiveness of Various Interventions for Nontraumatic Osteonecrosis of the Femoral Head.
In: Biomed Research International, Bd. 2018, 2790163
[PDF, 2MB]